In 2023, the total healthcare expenditure per capita was approximately ******* U.S. dollars. Followed by Norway, which spent ******* U.S. dollars per capita.

The average for 2021 based on 44 countries was 3554.27 U.S. dollars. The highest value was in Switzerland: 11262.23 U.S. dollars and the lowest value was in Ukraine: 369.9 U.S. dollars. The indicator is available from 2000 to 2023. Below is a chart for all countries where data are available.

In 2024, the United States had the ******* per capita health expenditure among OECD countries. At that time, per capita health expenditure in the U.S. amounted over ******** U.S. dollars, significantly higher than in Switzerland, the country with the ************** per capita health expenditure. Norway, Germany and, the Netherlands are also within the top five countries with the highest per capita health expenditure. The United States also spent the highest share of it’s gross domestic product on health care, with **** percent of its GDP spent on health care services. Health Expenditure in the U.S. The United States is the highest spending country worldwide when it comes to health care. In 2023, total health expenditure in the U.S. came close to **** trillion dollars. Expenditure as a percentage of GDP is projected to increase to approximately ** percent by the year 2033. Distribution of Health Expenditure in the U.S. Health expenditure in the United States is spread out across multiple categories such as nursing home facilities, home health care, and prescription drugs. As of 2023, the majority of health expenditure in the United States was spent on hospital care, accounting for a bit less than *** third of all health spending. Hospital care was followed by spending on physician and clinical services which accounted for ** percent of overall health expenditure.

The public and private per capita health expenditure differs significantly by country. As of 2024, the United States had by far the highest public per capita spending worldwide. Moreover, the U.S. had the second-highest private expenditure on health globally, just after Switzerland. Health expenditures globally Health expenditures include the consumption of health goods, services and public health programs as well as insurance and government spending. Globally, health expenditures are on the rise. Among all countries, the average per capita health expenditure is projected to see an increase of over 30 percent from the 2019 totals by the year 2050. Despite the growing expenditures, there are still countries with relatively low health expenditures. The countries with the lowest governmental health expenditure include South Sudan, Eritrea and Bangladesh. Health expenditures spotlight: the U.S. In 2023 the U.S. national health expenditure was at an all-time high. However, the projections indicate that total health expenditures will increase even more. The per capita health expenditures for the U.S. looked equally grim, with 2023 being the most expensive year for health care on record.

Health care expenditure quantifies the economic resources dedicated to health functions, excluding capital investment. Health care expenditure covers health care goods and services that are consumed by resident units, irrespective of where that consumption takes place (it may be in the rest of the world) or who is paying for it. As such, exports of health care goods and services (to non-resident units) are excluded, whereas imports of health care goods and services for final use are included.

Health care expenditure data provide information on expenditure broken down by function category (e.g. services of curative care, rehabilitative care, clinical laboratory, patient transport, prescribed medicines), provider category (e.g. hospitals, general practitioners) and financing scheme (e.g. social security, private insurance company, household). These categories form the 3 core classifications of the System of Health Accounts.

The complementary classification for the revenues broken down by health care financing schemes is also disseminated by Eurostat.

In 2019, people in Switzerland spent nearly 500 U.S. dollars that year on outpatient dental care (both private and public). This is much higher than in any other European country. This statistic depicts the per capita dental healthcare expenditure in Europe in 2019 in U.S. dollars.

The current healthcare spending per capita in Russia was forecast to continuously increase between 2024 and 2029 by in total ***** U.S. dollars (+***** percent). After the sixth consecutive increasing year, the spending is estimated to reach ******* U.S. dollars and therefore a new peak in 2029. Depicted here is the average per capita spending, in a given country or region, with regards to healthcare. The spending refers to the average current spending of both governments and consumers per inhabitant.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the current healthcare spending per capita in countries like Central & Western Europe and Eastern Europe.

Quantifies the economic resources dedicated to health functions, excluding capital investment. Concerns primarily healthcare goods and services consumed by residents, irrespective of where that consumption takes place or who is paying for it. Data are collected according to SHA2011 methodology.

This scatter chart displays hospital beds (per 1,000 people) against health expenditure per capita (current US$) in Europe. The data is about countries.

This dataset is about countries in Europe. It has 44 rows. It features 3 columns: region, and health expenditure per capita.

Consists of a range of medical and personal healthcare services consumed with the primary goal of alleviating pain and suffering and reducing or managing the deterioration in health status in patients with a degree of long-term dependency.

IntroductionDespite the improvements in European health systems, a large number of premature deaths are attributable to treatable mortality. Men make up the majority of these deaths, with a significant gap existing between women and men’s treatable mortality rate in the EU.AimThis study aims to identify the healthcare-related factors, including health expenditures, human and physical resources, and hospital services use associated with treatable mortality in women and men across European countries during the period 2011–2019.MethodsWe use Eurostat data for 28 EU countries in the period 2011–2019. We estimate a panel data linear regression with country fixed effects and quantile linear regression for men and women.ResultsThe results found (i) differences in drivers for male and female treatable mortality, but common drivers hold the same direction for both sexes; (ii) favorable drivers are GDP per capita, health expenditures, number of physicians per capita, and (only for men) the average length of a hospital stay, (iii) unfavorable drivers are nurses and beds per capita, although nurses are not significant for explaining female mortality.ConclusionPolicy recommendations may arise that involve an improvement in hospital bed management and the design of more specific policies aimed at healthcare professionals.

Mandatory (public) per capita expenditure on healthcare in Spain amounted to around 3,6005 U.S. dollars in 2023. In that year, voluntary per capita health spending in the European country reached almost 300 U.S. dollars. Total health expenditure per capita attained a value of almost 5,000 U.S. dollars. During the year depicted, health spending was equivalent to over nine of Spain's gross domestic product (GDP).

This scatter chart displays tax revenue (% of GDP) against health expenditure per capita (current US$) in Europe. The data is about countries.

This statistic shows the total healthcare expenditure per capita in the Netherlands from 1998 to 2022 (in euros). In 2022, the total healthcare expenditure per capita reached a value of approximately ***** euro. In the Netherlands, every resident or employee is obliged to take a basic health insurance to cover medical costs from, for example, visits to a general practitioner or the hospital.

The Dutch government decides on the cover provided by this package and health insurance companies are obliged to accept everyone who meets the requirements, regardless of age or state of health. An important characteristic of Dutch health insurance, though, is the so-called "principle of social solidarity": the overall costs of health care are paid by everybody. It is since 2008, for example, compulsory from the age of ** to pay a total mandatory excess before the basic health insurance reimburses medical costs. In this way, everybody contributes to certain types of healthcare such as maternity care.

In 2021, the total mandatory excess reached a value of *** euros. In 2005, the total health expenditure as share of GDP in the Netherlands reached a value of approximately ** percent. Subsequently, this increased to approximately **** percent in 2021. In 2021, the gross government expenses for primary care reached a value of approximately *** billion euros.

This bar chart displays health expenditure per capita (current US$) by currency using the aggregation average, weighted by population in Europe. The data is filtered where the date is 2021. The data is about countries per year.

This scatter chart displays health expenditure per capita (current US$) against incidence of HIV (per 1,000 uninfected population) in Europe. The data is about countries.

Health care expenditure quantifies the economic resources dedicated to health functions, excluding capital investment. Healthcare expenditure concerns itself primarily with healthcare goods and services that are consumed by resident units, irrespective of where that consumption takes place (it may be in the rest of the world) or who is paying for it. Data are collected according to SHA2011 methodology.

BackgroundPublic health expenditure is one of the fastest-growing spending items in EU member states. As the population ages and wealth increases, governments allocate more resources to their health systems. In view of this, the aim of this study is to identify the key determinants of public health expenditure in the EU member states.MethodsThis study is based on macro-level EU panel data covering the period from 2000 to 2018. The association between explanatory variables and public health expenditure is analyzed by applying both static and dynamic econometric modeling.ResultsAlthough GDP and out-of-pocket health expenditure are identified as the key drivers of public health expenditure, there are other variables, such as health system characteristics, with a statistically significant association with expenditure. Other variables, such as election year and the level of public debt, result to exert only a modest influence on the level of public health expenditure. Results also indicate that the aging of the population, political ideologies of governments and citizens’ expectations, appear to be statistically insignificant.ConclusionSince increases in public health expenditure in EU member states are mainly triggered by GDP increases, it is expected that differences in PHE per capita across member states will persist and, consequently, making it more difficult to attain the health equity sustainable development goal. Thus, measures to reduce EU economic inequalities, will ultimately result in reducing disparities in public health expenditures across member states.

The global health insurance market, valued at $2502.21 billion in 2025, is projected to experience robust growth, driven by factors such as rising healthcare costs, increasing prevalence of chronic diseases, expanding coverage mandates in several countries, and growing awareness of the importance of health insurance. The market's Compound Annual Growth Rate (CAGR) of 6.92% from 2025 to 2033 indicates a significant expansion. Key segments driving this growth include private health insurance, demonstrating higher growth potential compared to public health insurance due to increasing disposable incomes and consumer preference for personalized healthcare solutions. Within insurance types, life insurance and term insurance hold significant market shares, with term insurance showing strong growth potential owing to its affordability and adaptability to individual needs. The competitive landscape is characterized by a mix of established multinational players like UnitedHealth Group and Cigna, alongside rapidly growing regional and national insurers, leading to intense competition and innovation in product offerings and service delivery. Growth is geographically diverse. North America, particularly the US, will maintain a significant market share due to its advanced healthcare infrastructure and high per capita healthcare expenditure. However, the Asia-Pacific (APAC) region, particularly China and India, exhibits substantial growth potential fueled by increasing middle-class populations and rising healthcare awareness. Europe, with its established healthcare systems and expanding insurance penetration, will also contribute significantly. While regulatory changes and economic fluctuations pose challenges, the long-term outlook remains positive, driven by the fundamental need for affordable and accessible healthcare solutions, making health insurance a vital investment for individuals and governments alike.